MBC commonly shows a triple negative breast cancer phenotype, due to the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) [5], and is managed with surgical resection in combination with radiotherapy and chemotherapy [2]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.